Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 151–165 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3914 CLCNKA Gene Sequencing for Bartter Syndrome Type 4B (Genetic Test) This test identifies pathogenic variants in the CLCNKA gene associated with Bartter syndrome type 4B.	Whole Blood (EDTA) or Extracted DNA or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CLCNKA gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Avoid blood transfusion for 90 days prior", "Bring detailed clinical history", "Arrange for genetic counsellor consultation"] Indications ["Clinical suspicion of Bartter syndrome", "Family history of Bartter syndrome", "Unexplained electrolyte imbalances"] Measurement technique Confirm with laboratory Codes LOINC: 94257-2 ICD-10: E26.81, Z84.81, Z14.8 Clinical summary This test identifies pathogenic variants in the CLCNKA gene associated with Bartter syndrome type 4B.
TEST-6092 CLN8 Gene Neuronal Ceroid Lipofuscinosis Type 8 (NCL8) Genetic Test This genetic test evaluates the CLN8 gene for pathogenic variants associated with Neuronal Ceroid Lipofuscinosis type 8 (NCL8).	Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CLN8 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Review of relevant neurology reports, MRI findings, and prior genetic test results"] Indications ["Suspected diagnosis of NCL8", "Carrier screening", "Family planning", "Genetic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 94233-3 ICD-10: E75.4 Clinical summary This genetic test evaluates the CLN8 gene for pathogenic variants associated with Neuronal Ceroid Lipofuscinosis type 8 (NCL8).
TEST-6168 CNNM2 Gene Hypomagnesemia Type 6 Genetic Test This test detects pathogenic variants in the CNNM2 gene associated with Hypomagnesemia Type 6, a rare autosomal dominant disorder affecting magnesium metabolism.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CNNM2 gene", "Zygosity of variants"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Pre-test genetic counselling is mandatory"] Indications ["Individuals and families with a history of magnesium metabolism disorders", "Diagnosis of Hypomagnesemia Type 6"] Measurement technique Confirm with laboratory Codes LOINC: 82319-8 ICD-10: E83.42 Clinical summary This test detects pathogenic variants in the CNNM2 gene associated with Hypomagnesemia Type 6, a rare autosomal dominant disorder affecting magnesium metabolism.
TEST-4090 CNTN1 Gene Genetic Test (Compton-North Congenital Myopathy) This test identifies pathogenic variants in the CNTN1 gene, confirming the genetic basis for Compton-North congenital myopathy.	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CNTN1 gene coding region variants", "Pathogenic mutations"] Parameters [] Preparation ["Inform team of recent blood transfusion or stem cell transplant", "Reschedule if febrile >38.5°C"] Indications ["Suspected Compton-North congenital myopathy", "Family history of congenital myopathy", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 56267-3 ICD-10: G71.2 Clinical summary This test identifies pathogenic variants in the CNTN1 gene, confirming the genetic basis for Compton-North congenital myopathy.
TEST-4150 CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test This test identifies pathogenic variants within the CNTNAP2 gene associated with cortical dysplasia-focal epilepsy syndrome.	Peripheral blood (3–5 mL EDTA), FTA card spot, or extracted DNA (≥1 µg)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CNTNAP2 gene", "Deep intronic variants", "Copy-number variants"] Parameters [] Preparation ["Pre-test genetic counselling session mandatory", "Detailed pedigree documentation required"] Indications ["Diagnosis of cortical dysplasia-focal epilepsy syndrome", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 78025-5 ICD-10: Q04.3, G40.0 Clinical summary This test identifies pathogenic variants within the CNTNAP2 gene associated with cortical dysplasia-focal epilepsy syndrome.
TEST-5669 COCH Gene Deafness, Autosomal Dominant Type 9 Genetic Test This test identifies pathogenic variants in the COCH gene associated with autosomal dominant non-syndromic hearing loss type 9 (DFNA9). It uses Next Generation Sequencing (NGS) for...	Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COCH gene", "Exons and splice-site junctions of the COCH gene"] Parameters [] Preparation ["No fasting required", "No special dietary restrictions", "Pre-genetic counselling session recommended"] Indications ["Clinical suspicion of DFNA9", "Adults with post-lingual hearing loss", "Family history of hereditary hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.3 Clinical summary This test identifies pathogenic variants in the COCH gene associated with autosomal dominant non-syndromic hearing loss type 9 (DFNA9). It uses Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-4553 COG1 Gene Glycosylation Disorder Type 2g (CDG-2g) Genetic Test This genetic test identifies pathogenic variants in the COG1 gene associated with congenital disorder of glycosylation type IIg.	Peripheral whole blood (EDTA) or Dry Blood Spot (DBS)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COG1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your physician."] Indications ["Diagnosis of congenital disorder of glycosylation type IIg (CDG-2g)", "Evaluation of patients with suspected neurometabolic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-4 ICD-10: E77.8 Clinical summary This genetic test identifies pathogenic variants in the COG1 gene associated with congenital disorder of glycosylation type IIg.
TEST-6272 COG5 Gene Glycosylation Disorder Type 2I Genetic Test This test analyzes the COG5 gene for pathogenic variants associated with Congenital Disorder of Glycosylation type IIi (CDG-2I). It uses Next Generation Sequencing (NGS) for compre...	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COG5 gene", "Congenital Disorder of Glycosylation type IIi (CDG-2I)"] Parameters [] Preparation [] Indications ["Suspected Congenital Disorder of Glycosylation type IIi (CDG-2I)", "Family history of COG5-related disease"] Measurement technique Confirm with laboratory Codes LOINC: 83240-0 ICD-10: E77.8 Clinical summary This test analyzes the COG5 gene for pathogenic variants associated with Congenital Disorder of Glycosylation type IIi (CDG-2I). It uses Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-6263 COG6 Gene Glycosylation Disorder Type 3 Genetic Test This genetic test identifies pathogenic variants in the COG6 gene, which are responsible for Congenital Disorder of Glycosylation Type 3.	Whole Blood (EDTA), FTA Card, Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COG6 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected Congenital Disorder of Glycosylation Type 3", "Multisystem involvement with metabolic abnormalities", "Family history of CDG Type 3"] Measurement technique Confirm with laboratory Codes LOINC: 94146-5 ICD-10: E77.8, Z82.79, Z13.228 Clinical summary This genetic test identifies pathogenic variants in the COG6 gene, which are responsible for Congenital Disorder of Glycosylation Type 3.
TEST-5075 COL11A2 Gene Fibrochondrogenesis Type 2 Genetic Test This genetic test evaluates the COL11A2 gene for pathogenic variants associated with Fibrochondrogenesis Type 2.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in COL11A2 gene", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variants (CNVs)"] Parameters [] Preparation [] Indications ["Prenatal diagnosis of Fibrochondrogenesis Type 2", "Carrier screening for Fibrochondrogenesis Type 2", "Familial risk counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21698-3 ICD-10: Q77.5 Clinical summary This genetic test evaluates the COL11A2 gene for pathogenic variants associated with Fibrochondrogenesis Type 2.
TEST-3925 COL12A1 Gene Bethlem Myopathy Type 2 Genetic Test This test evaluates the COL12A1 gene for pathogenic variants associated with Bethlem myopathy type 2.	Whole Blood, Buccal Swab, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL12A1 gene", "Full gene coverage including intron-exon boundaries"] Parameters [] Preparation ["No fasting required", "No specific medication or diet instructions"] Indications ["Suspected diagnosis of Bethlem myopathy type 2", "Family history of collagen VI-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 92807-5 ICD-10: G71.0 Clinical summary This test evaluates the COL12A1 gene for pathogenic variants associated with Bethlem myopathy type 2.
TEST-5936 COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test This genetic test detects pathogenic variants in the COL12A1 gene associated with Ullrich congenital muscular dystrophy type 2.	Peripheral whole blood, extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL12A1 gene"] Parameters [] Preparation ["Genetic counselling is mandatory prior to testing"] Indications ["Individuals presenting with clinical features suggestive of Ullrich congenital muscular dystrophy type 2", "Carrier testing", "Reproductive planning in families with known COL12A1 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 74834-3 ICD-10: G71.0 Clinical summary This genetic test detects pathogenic variants in the COL12A1 gene associated with Ullrich congenital muscular dystrophy type 2.
TEST-5154 COL17A1 Gene Epidermolysis Bullosa, Junctional Genetic Test This test evaluates the COL17A1 gene for mutations associated with junctional epidermolysis bullosa (JEB). It uses Next-Generation Sequencing (NGS) to provide comprehensive coverag...	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COL17A1 gene sequence", "Pathogenic variants in COL17A1"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions unless advised by physician"] Indications ["Clinical suspicion of junctional epidermolysis bullosa", "Confirmed family history of COL17A1-related disorders", "Need for definitive molecular diagnosis", "Guidance for wound care and nutritional management", "Family genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 82160-5 ICD-10: Q81.1 Clinical summary This test evaluates the COL17A1 gene for mutations associated with junctional epidermolysis bullosa (JEB). It uses Next-Generation Sequencing (NGS) to provide comprehensive coverage of the gene.
TEST-4741 COL2A1 Gene Osteoarthritis with Mild Chondrodysplasia Genetic Test This test evaluates the COL2A1 gene for pathogenic variants associated with early-onset osteoarthritis and mild chondrodysplasia.	Whole Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL2A1 gene", "Copy Number Variants (CNVs) in the COL2A1 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counseling session", "Provide detailed clinical history and family history"] Indications ["Diagnosis of early-onset osteoarthritis with mild chondrodysplasia", "Family risk assessment for COL2A1-related disorders", "Differentiation from other forms of arthritis"] Measurement technique Confirm with laboratory Codes LOINC: 101454-2 ICD-10: M19.90 Clinical summary This test evaluates the COL2A1 gene for pathogenic variants associated with early-onset osteoarthritis and mild chondrodysplasia.
TEST-2466 COL2A1 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test This test identifies pathogenic variants within the COL2A1 gene associated with otospondylomegaepiphyseal dysplasia (OSMED) and related type II collagenopathies.	Whole blood (2–3 mL EDTA) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL2A1 gene"] Parameters [] Preparation ["No fasting required", "No medication changes needed", "Inform phlebotomist if on anticoagulants"] Indications ["Suspected otospondylomegaepiphyseal dysplasia (OSMED)", "Suspected Stickler syndrome", "Family history of type II collagenopathies"] Measurement technique Confirm with laboratory Codes LOINC: 81305-2 ICD-10: Q77.8 Clinical summary This test identifies pathogenic variants within the COL2A1 gene associated with otospondylomegaepiphyseal dysplasia (OSMED) and related type II collagenopathies.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.